Date:
April 25, 2024
Time:
10 AM MDT | 12 PM EDT
As technological progress reshapes the landscape of scientific inquiry, the ethical considerations surrounding public health research become increasingly complex. Join us for a stimulating discussion on the ethical dimensions of life sciences, focusing on pressing issues within the realm of public health.
Our session will delve into topics such as genetic engineering, human clinical trials, data privacy, and the ethical utilization of emerging AI technologies. Through real-world case studies and expert analysis, we’ll explore ethical decision-making processes and advocate for a conscientious approach to scientific pursuits that prioritize the well-being of individuals and communities alike.
The 50-min session will be followed by a 10-min Q&A.
About the speaker
Daniel Wasser
Scientific Director, Medical communications
Daniel Wasser, MD is a hardworking veteran medical communications professional and physician who brings years of clinical, as well as content development, experience in the pharma/device/biotech industry to any project he takes on. He has extensive experience in promotional marketing in both the US and EU markets and has worked in a wide variety of therapeutic areas delivering innovative and high-quality tactics and strategy.
Leave a Reply